725
Views
8
CrossRef citations to date
0
Altmetric
Review

Current Advances and Strategies Towards Fully Automated Sample Preparation for Regulated LC–MS/MS Bioanalysis

, &
Pages 2441-2459 | Published online: 11 Nov 2014

References

  • Jemal M , XiaYQ. LC–MS Development strategies for quantitative bioanalysis. Curr. Drug Metab. 7 (5), 491–502 (2006).
  • Jemal M , OuyangZ, XiaYQ. Systematic LC–MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography. Biomed. Chromatogr. 24 (1), 2–19 (2010).
  • Meadows K , OliverM, LiddicoatT. Comparison of sample preparation approaches for bioanalytical workflows and their affect on productivity. Bioanalysis5 (14), 1729–1733 (2013).
  • Beato BD , BriscoeC, RajaraoJ, SangsterT. Ask the Experts: increasing and maintaining productivity in the bioanalytical laboratory. Bioanalysis5 (14), 1715–1722 (2013).
  • Allinson JL , BlickKE, CohenL, HigtonD, LiM. Ask the experts: automation: part I. Bioanalysis5 (16), 1953–1962 (2013).
  • Miller V , ShoupR, SzapacsM, WangJ, YuanL, TweedJ. Ask the experts: automation: part II. Bioanalysis5 (17), 2085–2094 (2013).
  • Shen JX . Regulated bioanalytical laboratory automation: where we came from, where we are and where we are going. Bioanalysis3 (13), 1415–1418 (2011).
  • Li M . Automation in the bioanalytical laboratory: what is the future?Bioanalysis5 (23), 2859–2861 (2013).
  • Chang MS , JiQ, ZhangJ, El-ShourbagyTA. Historical review of sample preparation for chromatographic bioanalysis: pros and cons. Drug Dev. Res. 68 (3), 107–133 (2007).
  • Chiu ML , LawiW, SnyderST, WongPK, LiaoJC, GauV. Matrix effects – a challenge toward automation of molecular analysis. J. Assoc. Lab. Autom. 15, 233–242 (2010).
  • Nováková L , VlckováH. A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation. Anal. Chim. Acta. 656 (1−2), 8–35 (2009).
  • Matuszewski BK , ConstanzerML, Chavez-EngCM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC–MS/MS. Anal. Chem. 75 (13), 3019–3030 (2003).
  • King R , BonfiglioR, Fernandez-MetzlerC, Miller-SteinC, OlahT. Mechanistic investigation of ionization suppression in electrospray ionization. J. Am. Soc. Mass Spectrom. 11 (11), 942–950 (2000).
  • Hempenius J , WielingJ, JonkmanJH, de NoordOE, CoenegrachtPM, DoornbosDA. Development of a laboratory robotic system for automated bioanalytical methods. I. The determination of theophylline in human plasma: a comparison between the robotized and manual method. J. Pharm. Biomed. Anal. 8 (4), 313–320 (1990).
  • Allanson JP , BiddlecombeRA, JonesAE, PleasanceS. The use of automated solid phase extraction in the ‘96 well’ format for high throughput bioanalysis using liquid chromatography coupled to tandem mass spectrometry. Rapid Commun. Mass Spectrom. 10 (7), 811–816 (1996).
  • Kaye B , HerronWJ, MacraePVet al. Rapid, solid phase extraction technique for the high-throughput assay of darifenacin in human plasma. Anal. Chem. 68 (9), 1658–1660 (1996).
  • Janiszewski J , SchneiderRP, HoffmasterK, SwydenM, WellsD, FoudaH. Automated sample-preparation using membrane microtiter extraction for bioanalytical mass spectrometry. Rapid Commun. Mass Spectrom. 11 (9), 1033–1037 (1997).
  • Vogeser M , KirchhoffF. Progress in automation of LC–MS in laboratory medicine. Clin. Biochem. 44 (1), 4–13 (2011).
  • Xu RN , FanL, RieserMJ, El-ShourbagyTA. Recent advances in high-throughput quantitative bioanalysis by LC–MS/MS. J. Pharm. Biomed. Anal. 44 (2), 342–355 (2007).
  • Janiszewski JS , ListonTE, ColeMJ. Perspectives on bioanalytical mass spectrometry and automation in drug riscovery. Curr. Drug Metab. 9 (9), 986–994 (2008).
  • Kole PL , VenkateshG, KotechaJ, SheshalaR. Recent advances in sample preparation techniques for effective bioanalytical methods. Biomed. Chromatogr. 25 (1–2), 199–217 (2011).
  • Singleton C . Recent advances in bioanalytical sample preparation for LC–MS analysis. Bioanalysis4 (9), 1123–1140 (2012).
  • Shuo WZ , ZhangJ. Recent development in software and automation tools for high-throughput discovery bioanalysis. Bioanalysis4 (9), 1097–1109 (2012).
  • Tweed JA . Automation in LC–MS bioanalysis. In:Handbook of LC–MS Bioanalysis: Best Practices, Experimental Protocols, and Regulations. LiW, ZhangJ, TseFLS (Ed.). John Wiley & Sons, Inc, Hoboken, NJ, USA, 275–295 (2013).
  • Rauh M . LC–MS/MS for protein and peptide quantification in clinical chemistry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 883–884, 59–67 (2012).
  • Meesters RJ , HooffGP. State-of-the-art dried blood spot analysis: an overview of recent advances and future trends. Bioanalysis5 (17), 2187–2208 (2013).
  • Zheng N , ZengJ, JiQCet al. Improved liquid-liquid extraction with inter-well volume replacement dilution workflow and its application to quantify BMS-927711 in rat dried blood spots by UHPLC–MS/MS. J. Pharm. Biomed. Anal. 89, 240–250 (2014).
  • Jiang H , ZengJ, ZhengNet al. A convenient strategy for quantitative determination of drug concentrations in tissue homogenates using a liquid chromatography/tandem mass spectrometry assay for plasma samples. Anal. Chem. 83 (16), 6237–6244 (2011).
  • US Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation . US FDA, Silver Spring, MD, USA, May 2001.
  • Viswanathan CT , BansalS, BoothBet al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm. Res. 24 (10), 1962–1973 (2007).
  • Guideline on Bioanalytical Method Validation . European Medicines Agency. July 2011.
  • Whitmire M , AmmermanJ, de LisioPet al. LC–MS/MS bioanalysis method development, validation, and sample analysis: points to consider when conducting nonclinical and clinical studies in accordance with current regulatory guidances. J. Anal. Bioanal. Techniques doi: 10.4172/2155-9872.S4-001 (2014) (Epub ahead of print).
  • Mulvana DE . Critical topics in ensuring data quality in bioanalytical LC–MS method development. Bioanalysis2 (6), 1051–1072 (2010).
  • Jemal M , XiaYQ. Quantitative mass spectrometry considerations in a regulated environment. In:Mass Spectrometry for Drug Discovery and Drug Development (1st Edition). KorfmacherWA (Ed.). John Wiley & Sons, Inc., Hoboken, NJ, USA, 55–95 (2013).
  • Blair IA . Direct biofluid analysis systems. In:Encyclopedia of Drug Metabolism and Interactions, 6-Volume Set (1st Edition). LyubimovAV (Ed.). John Wiley & Sons, Inc., Hoboken, NJ, USA, 1–23 (2012).
  • McDowall R . Cost-effective and business-beneficial computer validation for bioanalytical laboratories. Bioanalysis3 (13), 1487–1499 (2011).
  • Lin Z , MoyerM, ZengJ, RajaraoJ, HayesM. Current understanding of bioanalysis data management and trend of regulations on data management. In:Handbook of LC–MS Bioanalysis: Best Practices, Experimental Protocols, and Regulations. LiW, ZhangJ, TseFLS (Ed.). John Wiley & Sons, Inc, Hoboken, NJ, USA, 97–107 (2013).
  • US Food and Drug Administration . 21 Code of Federal Regulations 58, Good Laboratory Practice for Non-Clinical Laboratory Studies. Office of the Federal Register, National Archives and Records Administration, Washington DC, USA (1978).
  • US Food and Drug Administration . 21 Code of Federal Regulations 11, Electronic Records; Electronic Signatures Final Rule. Office of the Federal Register, National Archives and Records Administration, Washington DC, USA (1997).
  • US Food and Drug Administration . Guidance for Industry: Part 11, Electronic Records; Electronic Signatures Scope and Application. US FDA, Silver Spring, MD, USA (2003).
  • Zhang N , YangA, RogersJD, ZhaoJJ. Quantitative analysis of simvastatin and its beta-hydroxy acid in human plasma using automated liquid–liquid extraction based on 96-well plate format and liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 34 (1), 175–187 (2004).
  • Pawula M , HawthorneG, SmithGTet al. Best practice in biological sample collection, processing, and storage for LC–MS in bioanalysis of drugs. In:Handbook of LC–MS Bioanalysis: Best Practices, Experimental Protocols, and Regulations. LiW, ZhangJ, TseFLS (Ed.), John Wiley & Sons, Inc, Hoboken, NJ, USA, 139–164 (2013).
  • Teitz DS , KhanS, PowellML, JemalM. An automated method of sample preparation of biofluids using pierceable caps to eliminate the uncapping of the sample tubes during sample transfer. J. Biochem. Biophys. Methods. 45 (2), 193–204 (2000).
  • Zheng N , BuzescuA, Pasas-FarmerSet al. A simplified and completely automated workflow for regulated LC–MS/MS bioanalysis using cap-piercing direct sampling and evaporation-free solid phase extraction. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 921–922, 64–74 (2013).
  • Gu H , DengY. Dilution effect in multichannel liquid-handling system equipped with fixed tips: problems and solutions for bioanalytical sample preparation. J. Assoc. Lab. Autom. 12, 355–362 (2007).
  • Ouyang Z , FedererS, PorterG, KaufmannC, JemalM. Strategies to maintain sample integrity using a liquid-filled automated liquid-handling system with fixed pipetting tips. J. Assoc. Lab. Autom. 13 (1), 24–32 (2008).
  • Gu H , UngerS, DengY. Automated TECAN programming for bioanalytical sample preparation with EZTECAN. Assay Drug Dev. Technol. 4 (6), 721–33 (2006).
  • Tweed JA , GuZ, XuHet al. Automated sample preparation for regulated bioanalysis: an integrated multiple assay extraction platform using robotic liquid handling. Bioanalysis2 (6), 1023–1040 (2010).
  • Ma J , ShiJ, LeHet al. A fully automated plasma protein precipitation sample preparation method for LC–MS/MS bioanalysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 862 (1–2), 219–26 (2008).
  • Zhang J , WeiS, AyresDW, SmithHT, TseFL. An automation-assisted generic approach for biological sample preparation and LC–MS/MS method validation. Bioanalysis3 (17), 1975–1986 (2011).
  • Tweed JA , WaltonJ, GuZ. Automated supported liquid extraction using 2D barcode processing for routine toxicokinetic portfolio support. Bioanalysis4 (3), 249–262 (2012).
  • Jiang H , OuyangZ, ZengJet al. A user-friendly robotic sample preparation program for fully automated biological sample pipetting and dilution to benefit the regulated bioanalysis. J. Lab. Autom. 17 (3), 211–21 (2012).
  • Li M , ChouJ, KingKW, YangL. ASPECTS: an automation-assisted SPE method development system. Bioanalysis5 (13), 1661–1676 (2013).
  • Li M , ChouJ, JingJet al. MARS: bringing the automation of small-molecule bioanalytical sample preparations to a new frontier. Bioanalysis4 (11), 1311–1326 (2012).
  • Biddlecombe RA , PleasanceS. Automated protein precipitation by filtration in the 96-well format. J. Chromatogr. B Biomed. Sci. Appl. 734 (2), 257–265 (1999).
  • Kocan G , QuangC, TangD. Evaluation of protein precipitation filter plates for high throughput LC–MS/MS bioanalytical sample preparation. Am. Drug Discov. 1 (3), 21–24 (2006).
  • Pucci V , Di PalmaS, AlfieriA, BonelliF, MonteagudoE. A novel strategy for reducing phospholipids-based matrix effect in LC–ESI-MS bioanalysis by means of HybridSPE. J. Pharm. Biomed. Anal. 50 (5), 867–871 (2009).
  • Ismaiel OA , ZhangT, JenkinsRG, KarnesHT. Investigation of endogenous blood plasma phospholipids, cholesterol and glycerides that contribute to matrix effects in bioanalysis by liquid chromatography/mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878 (31), 3303–3316 (2010).
  • Ardjomand-Woelkart K , KollroserM, LiL, DerendorfH, ButterweckV, BauerR. Development and validation of a LC–MS/MS method based on a new 96-well Hybrid-SPE™-precipitation technique for quantification of CYP450 substrates/metabolites in rat plasma. Anal. Bioanal. Chem. 400 (8), 2371–2381 (2011).
  • Ferreiro-Vera C , Priego-CapoteF, Luque de CastroMD. Comparison of sample preparation approaches for phospholipids profiling in human serum by liquid chromatography–tandem mass spectrometry. J. Chromatogr. A1240, 21–8 (2012).
  • Zeng W , XuY, ConstanzerM, WoolfEJ. Determination of sitagliptin in human plasma using protein precipitation and tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878 (21), 1817–1823 (2010).
  • Yuan L , JiangH, OuyangZet al. A rugged and accurate liquid chromatography–tandem mass spectrometry method for the determination of asunaprevir, an NS3 protease inhibitor, in plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 921–922, 81–86 (2013).
  • Zheng N , ZengJ, AkinsanyaBet al. A rapid, accurate and robust UHPLC–MS/MS method for quantitative determination of BMS-927711, a CGRP receptor antagonist, in plasma in support of non-clinical toxicokinetic studies. J. Pharm. Biomed. Anal. 83, 237–248 (2013).
  • Liu G , SnappHM, JiQC, ArnoldME. Strategy of accelerated method development for high-throughput bioanalytical assays using ultra high-performance liquid chromatography coupled with mass spectrometry. Anal. Chem. 81 (22), 9225–9232 (2009).
  • Jiang H , ZengJ, LiWet al. Practical and efficient strategy for evaluating oralabsolute bioavailability with an intravenous microdose of a stable isotopically labeled drug using a selected reaction monitoring mass spectrometry. Anal. Chem. 84 (22), 10031–10037 (2012).
  • Xu N , KimGE, GreggHet al. Automated 96-well liquid–liquid back extraction liquid chromatography–tandem mass spectrometry method for the determination of ABT-202 in human plasma. J. Pharm. Biomed. Anal. 36 (1), 189–195 (2004).
  • Pan J , JiangX, ChenY-L. Automatic supported liquid extraction (SLE) coupled with HILIC–MS/MS: an application to method development and validation of erlotinib in human plasma. Pharmaceutics2 (2), 105–118 (2010).
  • Wu S , LiW, MujamdarT, SmithT, BryantM, TseFL. Supported liquid extraction in combination with LC–MS/MS for high-throughput quantitative analysis of hydrocortisone in mouse serum. Biomed. Chromatogr. 24 (6), 632–638 (2010).
  • Li Y , EmmT, YeleswaramS. Simultaneous determination of fluoxetine and its major active metabolite norfluoxetine in human plasma by LC–MS/MS using supported liquid extraction. Biomed. Chromatogr. 25 (11), 1245–1251 (2011).
  • Pan J , FairSJ, MaoD. Quantitative analysis of skeletal symmetric chlorhexidine in rat plasma using doubly charged molecular ions in LC–MS/MS detection. Bioanalysis3 (12), 1357–1368 (2011).
  • Sun L , LiH, WilsonKet al. Ultrasensitive liquid chromatography–tandem mass spectrometric methodologies for quantification of five HIV-1 integrase inhibitors in plasma for a microdose clinical trial. Anal. Chem. 84 (20), 8614–8621 (2012).
  • Tan A , HangP, CoutureJ, HussainS, ValléeF. An evaporation-free solid-phase extraction method for rapid and accurate analysis of sumatriptan in human plasma by LC–MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 856 (1–2), 9–14 (2007).
  • Tan A , HussainS, ValléeF. Evaporation-free extraction and application in high-throughput bioanalysis by LC–MS-MS. LCGC N. Am. 27, 414 (2009).
  • Verdirame M , VenezianoM, AlfieriA, Di MarcoA, MonteagudoE, BonelliF. Turbulent flow chromatography TFC–tandem mass spectrometry supporting in vitro/vivo studies of NCEs in high-throughput fashion. J. Pharm. Biomed. Anal. 51 (4), 834–841 (2010).
  • Alnouti Y , SrinivasanK, WaddellD, BiH, KavetskaiaO, GusevAI. Development and application of a new online SPE system combined with LC–MS/MS detection for high throughput direct analysis of pharmaceutical compounds in plasma. J. Chromatogr. A1080 (2), 99–106 (2005).
  • Kataoka H , SaitoK. Recent advances in column switching sample preparation in bioanalysis. Bioanalysis4 (7), 809–832 (2012).
  • Kuklenyik Z , NeedhamLL, CalafatAM. Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction. Anal. Chem. 77 (18), 6085–6091 (2005).
  • Chassaing C , RobinsonS. Turbulent flow chromatography: an evolving solution for bioanalysis. Chromatogr. Today. 2, 20–24 (2009).
  • Yang GL , LiuHY. Application of monolithic stationary phases in solid-phase extraction and pharmaceutical analysis. Curr. Pharm. Anal. 6 (3), 213–224 (2010).
  • Rudewicz PJ . Turbulent flow bioanalysis in drug metabolism and pharmacokinetics. Bioanalysis3 (14), 1663–1671 (2011).
  • Chang M , LiY, AngelesRet al. Development of methods to monitor ionization modification from dosing vehicles and phospholipids in study samples. Bioanalysis3 (15), 1719–1739 (2011).
  • Zheng N , FungEN, BuzescuA, ArnoldME, ZengJ. Esterase inhibitors as ester-containing drug stabilizers and their hydrolytic products: potential contributors to the matrix effects on the bioanalysis by liquid chromatography tandem mass spectrometry. Rapid Commun. Mass Spectrom. 26 (11), 1291–304 (2012).
  • Fung EN , ZhengN, ArnoldME, ZengJ. Effective screening approach to select esterase inhibitors used for stabilizing ester-containing prodrugs analyzed by LC–MS/MS. Bioanalysis2 (4), 733–743 (2010).
  • Jiang H , ZengJ, DengYet al. A rugged and accurate liquid chromatography–tandem mass spectrometry method for quantitative determination of BMS-790052 in plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879 (22), 2064–2072 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.